PAGANIN, MADDALENA
 Distribuzione geografica
Continente #
NA - Nord America 1.487
EU - Europa 494
AS - Asia 184
AF - Africa 10
SA - Sud America 4
OC - Oceania 2
Totale 2.181
Nazione #
US - Stati Uniti d'America 1.483
IT - Italia 370
SG - Singapore 73
CN - Cina 72
DE - Germania 37
VN - Vietnam 32
FI - Finlandia 19
SE - Svezia 17
GB - Regno Unito 15
FR - Francia 11
ES - Italia 8
UA - Ucraina 8
CM - Camerun 6
CA - Canada 4
IN - India 3
NL - Olanda 3
BR - Brasile 2
EG - Egitto 2
ET - Etiopia 2
HK - Hong Kong 2
RO - Romania 2
VE - Venezuela 2
AU - Australia 1
CH - Svizzera 1
IE - Irlanda 1
NZ - Nuova Zelanda 1
PH - Filippine 1
RU - Federazione Russa 1
SK - Slovacchia (Repubblica Slovacca) 1
TR - Turchia 1
Totale 2.181
Città #
Fairfield 248
Chandler 203
Woodbridge 146
Ashburn 124
Houston 103
Cambridge 90
Seattle 82
Wilmington 79
Ann Arbor 73
Singapore 64
Milan 38
Dong Ket 32
Padova 30
San Diego 30
Jacksonville 27
Princeton 27
Des Moines 24
Bologna 20
Rome 19
Turin 17
Medford 16
Boardman 15
Santa Clara 14
Beijing 13
Munich 12
Nanjing 12
Naples 12
Verona 12
Desio 8
Cagliari 6
Pisa 6
Brescia 5
Genoa 5
Helsinki 5
London 5
Loreggia 5
New York 5
Corridonia 4
Falls Church 4
Hebei 4
Lavis 4
Shenyang 4
Vicenza 4
Aidone 3
Breda 3
Chicago 3
Florence 3
Nanchang 3
North York 3
Siena 3
Trento 3
Treviso 3
Verrua Savoia 3
Vittuone 3
Altedo 2
Atrani 2
Aversa 2
Azzano San Paolo 2
Badoere 2
Bastia umbra 2
Bucharest 2
Budrio 2
Cairo 2
Coreno Ausonio 2
Davoli 2
Farra di Soligo 2
Fontevivo 2
Giaveno 2
Hefei 2
Hong Kong 2
Isola della Scala 2
Jiaxing 2
Jinan 2
Kharkiv 2
Limena 2
Lodi 2
Los Angeles 2
Maracaibo 2
Mercato San Severino 2
Monza 2
Nürnberg 2
Poggiomarino 2
Poirino 2
Redwood City 2
Rimini 2
Rockville 2
Sant'Angelo Lodigiano 2
Sant'Antimo 2
Silea 2
São Paulo 2
Talla 2
Tappahannock 2
Valsamoggia 2
Venice 2
Vimercate 2
Ancona 1
Arosio 1
Bergamo 1
Bonn 1
Borgomanero 1
Totale 1.776
Nome #
"High Risk" Acute Lymphoblastic Leukemia 419
AKR1C enzymes sustain therapy resistance in paediatric T-ALL 136
Extracellular ATP signaling during differentiation of C2C12 skeletal muscle cells: role in proliferation 130
Acute lymphoblastic leukemia with t(4;11) in children 1 year and older: The 'big sister' of the infant disease? 123
Genetic loss of SH2B3 in acute lymphoblastic leukemia 110
Activating mutations in the NT5C2 nucleotidase gene drive chemotherapy resistance in relapsed ALL. 108
The presence of mutated and deleted PTEN is associated with an increased risk of relapse in childhood T cell acute lymphoblastic leukaemia treated with AIEOP-BFM ALL protocols 97
Phosphoproteomic analysis reveals hyperactivation of mTOR/STAT3 and LCK/Calcineurin axes in pediatric early T-cell precursor ALL 96
DNA methyltransferase 3a hot-spot locus is not mutated in pediatric patients affected by acute myeloid or T-cell acute lymphoblastic leukemia: an Italian study. 94
Comparative sequence analysis of incomplete DJH and TCR gene rearrangements in children with relapses of T-ALL 91
Oncogenic IL7R gain-of-function mutations in childhood T-cell acute lymphoblastic leukemia. 91
Large-scale circular RNA deregulation in T-ALL: Unlocking unique ectopic expression of molecular subtypes 84
Molecular pathogenesis and targeted therapies for NOTCH1-induced T-cell acute lymphoblastic leukemia. 83
Postinduction minimal residual disease monitoring by polymerase chain reaction in children with acute lymphoblastic leukemia. 82
CRLF2 over-expression is a poor prognostic marker in children with high risk T-cell acute lymphoblastic leukemia 81
Minimal Residual Disease Monitoring In Acute Lymphoblastic Leukemia Patients Using Immune Receptor Sequencing 79
USP7 cooperates with NOTch1 to drive the oncogenic transcriptional program in T-cell leukemia 74
WT1 mutations in T-ALL 60
Minimal residual disease i san important predictive factor of out come in children with relapsed œhigh risk acute lymphoblastic leukemia. 57
Posttranslational Regulation of the Exon Skipping Machinery Controls Aberrant Splicing in Leukemia 54
CircFBXW7 in patients with T-cell ALL: depletion sustains MYC and NOTCH activation and leukemia cell viability 29
Either IL-7 activation of JAK-STAT or BEZ inhibition of PI3K-AKT-mTOR pathways dominates the single-cell phosphosignature of ex vivo treated pediatric T-cell acute lymphoblastic leukemia cells 20
Totale 2.198
Categoria #
all - tutte 7.372
article - articoli 6.620
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.992


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020280 0 0 0 21 39 25 38 43 48 36 18 12
2020/2021242 13 17 5 17 12 10 15 30 33 23 25 42
2021/2022341 6 19 65 12 22 11 35 35 16 1 43 76
2022/2023387 61 45 24 47 47 47 8 24 50 5 16 13
2023/2024383 11 29 29 25 26 41 27 53 41 19 43 39
2024/2025207 33 96 42 36 0 0 0 0 0 0 0 0
Totale 2.198